Organon (OGN) Non-Current Assets (2020 - 2026)

Organon (OGN) recorded quarterly Non-Current Assets of $8.1 billion in Q1 2026, down 5.3% quarter-over-quarter from $8.5 billion in Q4 2025, and down 8.21% on a YoY basis from $8.8 billion in Q1 2025.

Organon (OGN) Non-Current Assets (2020 - 2026) Analysis & Trends

Organon's Non-Current Assets history runs 7 years deep, the most recent figure standing at $8.1 billion for Q1 2026.

  • In Q1 2026, Non-Current Assets fell 8.21% year-over-year to $8.1 billion; the TTM figure through Mar 2026 stood at $34.3 billion (up 3.42% YoY), while the FY2025 annual figure was $8.5 billion, down 2.72% from the prior year.
  • Non-Current Assets was $8.1 billion for Q1 2026 at Organon, down from $8.5 billion in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $8.9 billion in Q2 2025 to a low of $6.8 billion in Q2 2022.
  • Historically, Non-Current Assets has averaged $7.7 billion across 5 years, with a median of $7.6 billion in 2024.
  • The sharpest annual moves came in 2025 and 2026: Non-Current Assets increased 16.18% in 2025, then declined 8.21% in 2026.
  • A 5-year view of Non-Current Assets shows it stood at $7.0 billion in 2022, then gained by 7.49% to $7.6 billion in 2023, then increased by 15.93% to $8.8 billion in 2024, then retreated by 2.72% to $8.5 billion in 2025, then fell by 5.3% to $8.1 billion in 2026.
  • The last three Non-Current Assets figures came in at $8.1 billion (Q1 2026), $8.5 billion (Q4 2025), and $8.9 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Gsk 93,026,132.38 Bn 93,026,127.42 Bn 7.76 Bn 60.81 Bn
2 Eli Lilly 1,022.62 Bn 1,017.34 Bn 16.22 Bn 61.74 Bn
3 Johnson & Johnson 570.65 Bn 548.59 Bn 15.96 Bn 141.72 Bn
4 AbbVie 398.73 Bn 389.38 Bn 10.78 Bn 102.93 Bn
5 Merck 295.53 Bn 289.88 Bn 12.09 Bn 125.00 Mn
6 Amgen 186.30 Bn 174.26 Bn 5.87 Bn 61.03 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn 37.64 Bn
8 Pfizer 146.09 Bn 133.32 Bn -1.21 Bn 165.18 Bn
9 Bristol Myers Squibb 114.98 Bn 104.53 Bn 8.07 Bn 59.27 Bn
10 Organon 3.49 Bn 2.37 Bn 783.00 Mn 8.06 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.06 Bn
Dec 31, 2025 8.52 Bn
Sep 30, 2025 8.85 Bn
Jun 30, 2025 8.88 Bn
Mar 31, 2025 8.79 Bn
Dec 31, 2024 8.75 Bn
Sep 30, 2024 8.00 Bn
Jun 30, 2024 7.65 Bn
Mar 31, 2024 7.70 Bn
Dec 31, 2023 7.55 Bn
Sep 30, 2023 6.96 Bn
Jun 30, 2023 7.02 Bn
Mar 31, 2023 6.98 Bn
Dec 31, 2022 7.02 Bn
Sep 30, 2022 6.85 Bn
Jun 30, 2022 6.84 Bn
Mar 31, 2022 6.88 Bn
Dec 31, 2021 6.92 Bn
Sep 30, 2021 7.01 Bn
Jun 30, 2021 7.00 Bn